14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 4552.T
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for JCR Pharmaceuticals Co.,Ltd. as stock downgraded to Sell Candidate.
(Updated on Jun 20, 2024)

Sell candidate since Jun 20, 2024 PDF

The JCR Pharmaceuticals Co.,Ltd. stock price gained 0.172% on the last trading day (Thursday, 20th Jun 2024), rising from JP¥583.00 to JP¥584.00. During the last trading day the stock fluctuated 2.59% from a day low at JP¥579.00 to a day high of JP¥594.00. The price has risen in 5 of the last 10 days and is up by 2.82% over the past 2 weeks. Volume fell on the last day by -114 thousand shares and in total, 360 thousand shares were bought and sold for approximately JP¥210.30 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -37.85% during the next 3 months and, with a 90% probability hold a price between JP¥272.48 and JP¥386.03 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

4552.T Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, May 29, 2024, and so far it has risen 8.96%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The JCR Pharmaceuticals Co.,Ltd. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at JP¥623.03. On a fall, the stock will find some support from the short-term average at JP¥583.29. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for JCR Pharmaceuticals Co.,Ltd. stock

JCR Pharmaceuticals Co.,Ltd. finds support from accumulated volume at JP¥577.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved JP¥15.00 between high and low, or 2.59%. For the last week, the stock has had daily average volatility of 2.24%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (4552.T) For The Upcoming Trading Day Of Friday 21st

For the upcoming trading day on Friday, 21st we expect JCR Pharmaceuticals Co.,Ltd. to open at JP¥585.67, and during the day (based on 14 day Average True Range), to move between JP¥565.19 and JP¥602.81, which gives a possible trading interval of +/-JP¥18.81 (+/-3.22%) up or down from last closing price. If JCR Pharmaceuticals Co.,Ltd. takes out the full calculated possible swing range there will be an estimated 6.44% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at JP¥577.00 (1.20%) than the resistance at JP¥628.00 (7.53%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is JCR Pharmaceuticals Co.,Ltd. stock A Buy?

JCR Pharmaceuticals Co.,Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.334 Sell Candidate Downgraded

Predicted Opening Price for JCR Pharmaceuticals Co.,Ltd. of Friday, June 21, 2024

Fair opening price June 21, 2024 Current price
JP¥585.67 ( 0.285%) JP¥584.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 4552.T

Fibonacci Support & Resistance Levels

Level Price
R3 600.67 2.85%
R2 594.94 1.87%
R1 591.40 1.27%
Price 584.00
S1 579.94 -0.696%
S2 576.40 -1.30%
S3 570.67 -2.28%

Accumulated Volume Support & Resistance Levels

Level Price
R3 648.00 10.96%
R2 640.00 9.59%
R1 628.00 7.53%
Price 584.00
S1 577.00 -1.20%
S2 575.00 -1.54%
S3 563.00 -3.60%

4552 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 27, 2024 Sep 27, 2024 Sep 27, 2024 JP¥0 0%
2 Mar 28, 2024 Mar 28, 2024 Jun 27, 2024 JP¥10.00 1.72%
3 Sep 28, 2023 Sep 28, 2023 Dec 08, 2023 JP¥10.00 0.85%
4 Mar 30, 2023 Mar 30, 2023 Mar 30, 2023 JP¥10.00 0.653%
5 Sep 29, 2022 Sep 29, 2022 Sep 29, 2022 JP¥10.00 0.457%

FAQ

What is the symbol for JCR Pharmaceuticals Co.,Ltd. Stock and on which exchange is it traded?
The symbol for JCR Pharmaceuticals Co.,Ltd. is 4552.T and it is traded on the TYO (Tokyo Stock Exchange).

Should I buy or sell JCR Pharmaceuticals Co.,Ltd. Stock?
JCR Pharmaceuticals Co.,Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy JCR Pharmaceuticals Co.,Ltd. Stock?
JCR Pharmaceuticals Co.,Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy JCR Pharmaceuticals Co.,Ltd. Stock.

What's the current price of JCR Pharmaceuticals Co.,Ltd. Stock?
As of the end of day on the Jun 20, 2024, the price of an JCR Pharmaceuticals Co.,Ltd. (4552.T) share was JP¥584.00.

What is the 52-week high and low for JCR Pharmaceuticals Co.,Ltd. Stock?
The 52-week high for JCR Pharmaceuticals Co.,Ltd. Stock is JP¥1,567.00 and the 52-week low is JP¥522.00.

What is the market capitalization of JCR Pharmaceuticals Co.,Ltd. Stock?
As of the Jun 20, 2024, the market capitalization of JCR Pharmaceuticals Co.,Ltd. is 72.761B.

When is the next earnings date for JCR Pharmaceuticals Co.,Ltd.?
The upcoming earnings date for JCR Pharmaceuticals Co.,Ltd. is Jul 24, 2024.
Click to get the best stock tips daily for free!

About JCR Pharmaceuticals Co.,Ltd.

JCR Pharmaceuticals Co.Ltd. JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for t... 4552.T Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT